Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions—Part I
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Introduction: A nomenclature is defined as a classification system for assigning names or terms in a scientific discipline. A nosology more specifically provides a scientific classification system for diseases or disorders. Historically, the nosologic system informing female sexual dysfunction (FSD) has been the system developed by the American Psychiatric Association in its Diagnostic and Statistical Manual of Mental Disorders (DSM-III through DSM-5). Experts have recognized limitations of its use in clinical practice, including concerns that the DSM-5 system does not adequately reflect the spectrum and presentation of FSD. Aim: To review the central considerations and issues that underlie the development of a new evidence-based nomenclature that reliably and validly defines the categories of FSD and will effectively function in clinical and research settings, serve as a basis for International Classification of Diseases (ICD) codes, and provide regulatory guidance for interventions designed as FSD treatments. Methods: The International Society for the Study of Women's Sexual Health conducted a 2-day conference on nomenclature for FSD in December 2013. Key opinion leaders representing diverse areas of expertise discussed ideal characteristics, existing DSM definitions, and current and future ICD coding to develop consensus for this new nomenclature. Main Outcome Measure: A comprehensive appreciation of the parameters and characteristics essential to a new FSD nomenclature and terminology that will serve as the principal nosology for the description and diagnosis of FSD. Results: A critical appraisal of the essential elements of a classification system for diagnosing FSD was accomplished. The applicability of DSM-5 FSD definitions was challenged; and the considerations for developing a new nomenclature were discussed, including comorbidities, clinical thresholds, alternative etiologies, and validity. Conclusion: The essential elements for developing a valid, reliable, credible, and clinically applicable nosology for FSD were enumerated as a preamble to constructing the actual nosologic system (Part II).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, C. B. (2000) · Journal of Sex & Marital Therapy · doi:10.1080/009262300278597 · Cited by 6,593
Sexual Dysfunction in the United States: Prevalence and Predictors
Laumann, E. O., Paik, A., & Rosen, R. C. (1999) · JAMA · doi:10.1001/jama.281.6.537 · Cited by 5,119
Self-citationA Study of sexuality and health among older adults in the United States
Lindau, S. T., Schumm, L. P., Laumann, E. O., Levinson, W., O'Muircheartaigh, C. A., & Waite, L. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067423 · Cited by 2,211
The pre-therapeutic classification of co-morbidity in chronic disease
Feinstein, A. R. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90054-8 · Cited by 1,544
Sexual Problems and Distress in United States Women: Prevalence and Correlates
Shifren, J. L., Monz, B. U., Russo, P. A., Segreti, A., & Johannes, C. B. (2008) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181898cdb · Cited by 1,394
Kaplan, H. S. (1980) · The Interface Between the Psychodynamic and Behavioral Therapies · doi:10.1007/978-1-4613-3000-4_25 · Cited by 1,070
Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
Shifren, J. L., Braunstein, G. D., Simon, J. A., Casson, P. R., Buster, J. E., Redmond, G. P., Burki, R. E., Ginsburg, E. S., Rosen, R. C., Leiblum, S. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431002 · Cited by 954
Self-citationCauses of sexual dysfunction: The role of anxiety and cognitive interference.
Barlow, D. H. (1986) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.54.2.140 · Cited by 896
Pfaus, J. G. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01309.x · Cited by 678
McCabe, M. P., Sharlip, I. D., Atalla, E., Balon, R., Fisher, A. D., Laumann, E., Lee, S. W., Lewis, R., & Segraves, R. T. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2015.12.019 · Cited by 605 · cited 1×
“Conclusions of this meeting, including recommended definitions of sexual dysfunctions and their levels of evidence, were published in 2016.(5)”
BackgroundSelf-citation
Research works printed but not linked: 13
- American Psychiatric Association, 2013, Diagnostic and Statistical Manual of Mental Disorders, 10.1176/appi.books.9780890425596 · DOI · Paper page
- Derogatis, 2011, Should sexual desire and arousal disorders in women be merged?, Arch Sex Behav, 40, 217, 10.1007/s10508-010-9677-1 · DOI
- Clayton, 2010, Do clinical research data support sexual desire and arousal disorders as being distinct diagnoses?, J Sex Med, 7, S143
- Derogatis, 2010, Do multiple convergent measures of female sexual dysfunction support sexual desire and arousal disorders as distinct diagnoses?, J Sex Med, 7, S142
- Kendell, 2003, Distinguishing between the validity and utility of psychiatric diagnoses, Am J Psychiatry, 160, 4, 10.1176/appi.ajp.160.1.4 · DOI · Paper page
- Sand, 2007, Women's endorsement of models of sexual response: the Nurses Sexuality Study, J Sex Med, 4, 708, 10.1111/j.1743-6109.2007.00496.x · DOI · Paper page
- Giles, 2009, Conceptualizing women's sexual functioning: linear versus circular models of sexual response, J Sex Med, 6, 2761, 10.1111/j.1743-6109.2009.01425.x · DOI · Paper page
- World Health Organization, 2011, International statistical classification of diseases and related health problems. 10th rev, edition 2010 (ICD-10 4th ed)
- Balon, 2014, Female sexual interest/arousal disorder: a diagnosis out of thin air, Arch Sex Behav, 43, 1227, 10.1007/s10508-013-0247-1 · DOI
- First, 2009, Harmonization of ICD-11 and DSM-V: opportunities and challenges, Br J Psychiatry, 195, 382, 10.1192/bjp.bp.108.060822 · DOI · Paper page
- Clayton, 2006, Burden of phase-specific sexual dysfunction with SSRIs, J Affect Disord, 91, 27, 10.1016/j.jad.2005.12.007 · DOI
- Balon, 2006, SSRI-associated sexual dysfunction, Am J Psychiatry, 163, 1504, 10.1176/ajp.2006.163.9.1504 · DOI · Paper page
- Kerlinger, 1973, Foundations of behavioral research
Cited by
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials
Kingsberg, S. A., Clayton, A. H., Portman, D., Williams, L. A., Krop, J., Jordan, R., Lucas, J., & Simon, J. A. (2019) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003500 · Cited by 294
Scoring and Interpretation of the FSFI: What can be Learned From 20 Years of use?
Meston, C. M., Freihart, B. K., Handy, A. B., Kilimnik, C. D., & Rosen, R. C. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2019.10.007 · Cited by 276
Self-citationGlobal Consensus Position Statement on the Use of Testosterone Therapy for Women
Davis, S. R., Baber, R., Panay, N., Bitzer, J., Perez, S. C., Islam, R. M., Kaunitz, A. M., Kingsberg, S. A., Lambrinoudaki, I., Liu, J., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01603 · Cited by 270
Self-citationClayton, A. H., Goldstein, I., Kim, N. N., Althof, S. E., Faubion, S. S., Faught, B. M., Parish, S. J., Simon, J. A., Vignozzi, L., Christiansen, K., et al. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.11.002 · Cited by 226
Self-citationGlobal Consensus Position Statement on the Use of Testosterone Therapy for Women
Davis, S. R., Baber, R., Panay, N., Bitzer, J., Cerdas Perez, S., Islam, R. M., Kaunitz, A. M., Kingsberg, S. A., Lambrinoudaki, I., Liu, J., et al. (2019) · Climacteric · doi:10.1080/13697137.2019.1637079 · Cited by 113
Self-citationGoldstein, I., Komisaruk, B. R., Pukall, C. F., Kim, N. N., Goldstein, A. T., Goldstein, S. W., Hartzell-Cushanick, R., Kellogg-Spadt, S., Kim, C. W., Jackowich, R. A., et al. (2021) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2021.01.172 · Cited by 96
Self-citationPrevalence of Persistent Genital Arousal Disorder in 2 North American Samples
Jackowich, R. A., & Pukall, C. F. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.09.004 · Cited by 34
Pease, E. R., Ziegelmann, M., Vencill, J. A., Kok, S. N., Collins, C. S., & Betcher, H. K. (2022) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2021.05.001 · Cited by 22
Persistent Genital Arousal Disorder: a Biopsychosocial Framework
Jackowich, R. A., & Pukall, C. F. (2020) · Current Sexual Health Reports · doi:10.1007/s11930-020-00268-2 · Cited by 17
Legal and policy implications in Mexico of changes in ICD-11 paraphilic disorders
Martínez-López, J. N. I., Robles, R., Fresán, A., Montis, I. A.-D., Kismödi, E., Medina-Mora, M. E., & Reed, G. M. (2019) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2019.07.022 · Cited by 9
Metadata
- Authors
- Derogatis, L. R., Sand, M., Balon, R., Rosen, R., & Parish, S. J.
- Venue
- The Journal of Sexual Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-12-01
- Volume
- 13
- Issue
- 12
- Pages
- 1881-1887
- ISSN
- 1743-6095 (ISSN-L)
- 1743-6109
- OpenAlex
- W2531135712
- Cited by
- 130
- References
- 35
- FWCI
- 13.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.